CDs are everywhere, even on the blog of Chancellor of Germany!
To my greatest surprise a cyclodextrin-related blog post may be found on the Bundeskanzlerin’s website. Angela Merkel awarded two young
Author: István Puskás
research chemist
HPBCD treatment for Niemann-Pick C: Mallinckrodt communicated results of clinical trial
Mallinckrodt Pharmaceuticals recently revealed findings of their completed registration trial for VTS-270 (Hydroxypropyl Betadex- HPBCD), a development product to treat
New Clinical Trial for Efficacy and Safety of Sugammadex in 0-2 Years Old Children
Federal Research Institute of Pediatric Hematology, Oncology and Immunology is about to launch a clinical study at Dmitry Rogachev National
Minimizing tissue reactions with cyclodextrins at infusion site of insulin therapy
A recently published patent application of Cell and Molecular Tissue Engineering LLC (WO2017180708) discloses a method of lowering the concentrations of
A patent application for potential medical use of CD-based (poly)catenanes
Researchers from Kumamoto University (Hidetoshi Arima, Keiichi Motoyama, Taishi Higashi) filed an international patent application on a novel synthesis of
HPBCD was tested for revealing the symptoms of Cockayne syndrome in mouse model: a surprise
Cockayne syndrome is a hereditary form of premature aging caused by a gene mutation. The disease affects more organs including